Skip to main content
. 2017 Jun 18;2017(6):CD004637. doi: 10.1002/14651858.CD004637.pub2

Comparison 6. Cephalosporin + antiprotozoal versus placebo.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Abdominal wound infection 1   Risk Ratio (M‐H, Fixed, 95% CI) Subtotals only
1.1 Abdominal hysterectomy 1 406 Risk Ratio (M‐H, Fixed, 95% CI) 1.0 [0.14, 7.03]
2 Urinary tract infection 1   Risk Ratio (M‐H, Fixed, 95% CI) Subtotals only
2.1 Vaginal hysterectomy 1 406 Risk Ratio (M‐H, Fixed, 95% CI) 0.5 [0.24, 1.04]
2.2 Abdominal hysterectomy 1 406 Risk Ratio (M‐H, Fixed, 95% CI) 0.27 [0.08, 0.96]
3 Pelvic infection 1   Risk Ratio (M‐H, Fixed, 95% CI) Subtotals only
3.1 Vaginal hysterectomy 1 406 Risk Ratio (M‐H, Fixed, 95% CI) 0.05 [0.01, 0.37]
4 Postoperative fever 1   Risk Ratio (M‐H, Fixed, 95% CI) Subtotals only
4.1 Vaginal hysterectomy 1 406 Risk Ratio (M‐H, Fixed, 95% CI) 0.5 [0.34, 0.73]
4.2 Abdominal hysterectomy 1 406 Risk Ratio (M‐H, Fixed, 95% CI) 0.79 [0.58, 1.09]
5 Need for therapeutic antibiotics 1   Risk Ratio (M‐H, Fixed, 95% CI) Subtotals only
5.1 Vaginal hysterectomy 1 406 Risk Ratio (M‐H, Fixed, 95% CI) 0.36 [0.19, 0.68]
5.2 Abdominal hysterectomy 1 406 Risk Ratio (M‐H, Fixed, 95% CI) 0.38 [0.15, 0.94]
6 Length of hospital stay 1   Mean Difference (IV, Fixed, 95% CI) Subtotals only
6.1 Abdominal hysterectomy 1 406 Mean Difference (IV, Fixed, 95% CI) ‐0.30 [‐0.60, ‐0.00]